Daiichi Sankyo

The Healthcare Partnership is launched

The company is headed by founder Duane Lacey (pictured), who has over 20 years’ experience within the industry having served in various roles for companies including AstraZeneca, Daiichi-Sankyo and Alliance

Roche preps new Kadcyla filings after phase 3 trial win

Meanwhile, moving Kadcyla up the treatment pathway should help keep the ADC – currently the smallest product of the three – ahead of emerging rivals, such as  Daiichi-Sankyo’s ADC trastuzumab deruxtecan

Daiichi-Sankyo takes rival to Roche’s Kadcyla into phase 3

If successful in phase 3, Daiichi-Sankyo’s drug could muscle into Kadcyla’s territory and provide another line of HER2 treatment in Kadcyla non-responders. ... therapy in patients with HER2 positive metastatic breast cancer,” said Gilles Gallant,

Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands

She has also served in various positions for Daiichi Sankyo, Novartis, Eli Lilly and GlaxoSmithKline.

Vernalis accepts £33m takeover offer from Ligand Pharma

If the deal goes through, Ligand will inherit a portfolio of more than eight fully-funded partnered programmes focused around central nervous system, oncology and inflammation, including collaborations with Servier, Daiichi ... Sankyo, Lundbeck, Asahi

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]